Hepatitis B-related end-stage liver disease.
Everhart
J E
JE
Hoofnagle
J H
JH
D006509:Hepatitis B / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D006513:Hepatitis B e Antigens / Q000096:biosynthesis; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D008103:Liver Cirrhosis / Q000209:etiology*; D008107:Liver Diseases / Q000209:etiology* / Q000401:mortality
D006513:Hepatitis B e Antigens; D016898:Interferon-alpha